Marinus Pharmaceuticals, Inc
MRNS
MRNS was delisted on the 10th of February, 2025.
38 hedge funds and large institutions have $54.3M invested in Marinus Pharmaceuticals, Inc in 2015 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 2 closing their positions.
550% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 2
41% more funds holding
Funds holding: 27 → 38 (+11)
38% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 8
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
26% less capital invested
Capital invested by funds: $73.2M → $54.3M (-$18.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Allianz Asset Management
Munich,
Germany
|
+$1.15M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$1.09M |
| 3 |
IHM
Iguana Healthcare Management
New York
|
+$1.06M |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$847K |
| 5 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$833K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$2.98M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.92M |
| 3 |
Goldman Sachs
New York
|
-$413K |
| 4 |
AIC
AWM Investment Company
New York
|
-$247K |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$43.8K |
MRNS Hedge Fund Activity: Q3 2015 in Review
38 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in Marinus Pharmaceuticals, Inc (MRNS) for Q3 2015, worth a combined $54.3M — down 26% from $73.2M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new MRNS positions and 2 closed out — a net gain of 11 holders — while 11 added to existing stakes and 8 trimmed.
The largest buyer was Allianz Asset Management, opening a new position worth an estimated $1.15M. The largest seller was Franklin Resources, cutting an estimated $2.98M.
- 38 institutional investors held Marinus Pharmaceuticals, Inc (MRNS) as of Q3 2015, up from 27 in Q2 2015.
- Funds reported $54.3M of Marinus Pharmaceuticals, Inc stock for Q3 2015, down 26% quarter-over-quarter.
- 13 funds opened new Marinus Pharmaceuticals, Inc positions in Q3 2015 and 2 closed out, a net change of +11 holders.
- The largest Marinus Pharmaceuticals, Inc buyer in Q3 2015 was Allianz Asset Management, an estimated $1.15M added.
- The largest Marinus Pharmaceuticals, Inc seller in Q3 2015 was Franklin Resources, an estimated $2.98M sold.
Based on aggregated 13F filings for Q3 2015.